Related Experiment Video
Updated: May 7, 2025

07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.7K
Quantification of Difference in Nonselectivity Between In Vitro Diagnostic Medical Devices
Pernille Kjeilen Fauskanger1,2, Sverre Sandberg1,3,4, Jesper Johansen5
1Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital, Bergen, Norway.
Biometrical Journal. Biometrische Zeitschrift
|January 3, 2025
Summary
This study introduces a new method to quantify nonselectivity differences (DINS) between in vitro diagnostic (IVD) medical devices (MDs). This measure helps assess the quality of IVD-MD method comparison studies for reliable patient care.
Area of Science:
- Medical Diagnostics
- Biostatistics
- Analytical Chemistry
Background:
- Accurate results from in vitro diagnostic (IVD) medical devices (MDs) are essential for patient care.
- Method comparison studies are used to assess IVD-MD performance but can be affected by various factors, including nonselectivity.
- Quantifying nonselectivity differences between IVD-MDs is crucial but historically lacking.
Purpose of the Study:
- To introduce a novel measure for quantifying differences in nonselectivity (DINS) between pairs of IVD-MDs.
- To develop a plug-in estimator for DINS and a criterion for identifying excessive DINS.
- To evaluate the performance of the DINS estimator using simulations and clinical data.
Main Methods:
- Developed a novel measure for quantifying differences in nonselectivity (DINS) using elements of ordinary least squares regression and IVD-MD repeatability variances.
- Introduced a plug-in estimator for DINS, linked to prediction interval widths.
- Employed Monte Carlo simulations and analyzed clinical data to assess the estimator's behavior.
Main Results:
- The proposed DINS measure effectively quantifies nonselectivity differences between IVD-MDs.
- The DINS estimator is significantly influenced by DINS and, to a lesser extent, by heteroskedasticity, with study design size modulating these effects.
- Simulations and clinical data confirmed that DINS impacts the estimator, validating its utility.
Conclusions:
- The novel DINS measure and its estimator provide a quantitative approach to assess nonselectivity in IVD-MDs.
- This metric aids in evaluating the quality of method comparison studies, ensuring reliable diagnostic results.
- The findings support improved quality control and performance assessment of IVD medical devices.

